Research demonstrates that these medicines affect early disease development by addressing critical pathophysiological mechanisms
No unexpected serious safety signals have been reported so far, but the full safety dataset will take TRIUMPH-1, TRIUMPH-2, TRIUMPH-3, and eventually TRIUMPH-CVOT to characterize
Improve digestion, energy, and nutrient absorptiondoctor-formulated
Switching to retatrutide Moving from a dual agonist (tirzepatide) to a triple agonist (retatrutide) is generally smoother because retatrutide maintains GLP-1 and GIP activation while adding glucagon receptor stimulation
Ganta says she considers her patients specific health profiles before prescribing GLP-1s, especially with older adults who have frailty, dementia, or another geriatric syndrome
Is GLP-1 the same as Ozempic